• SENSEX
    NIFTY 50
Market

Top brokerage calls for September 9: Kotak upgrades RBL Bank; Jefferies bullish on Coal India

Updated : 2019-09-09 07:56:33

Indian shares are likely to open in the green on Monday, tracking gains in Asia, as investors pinned expectations on likely stimulus to support growth in the world’s major economies. Global markets advanced on China's new stimulus plan and after Friday’s soft US jobs report raised expectations for a Federal Reserve rate cut. Among brokerages, Kotak upgraded RBL Bank to 'add' from 'reduce', while jefferies is bullish on Coal India. Here are the top brokerage calls for Monday:

<strong>Kotak Institutional Equities on RBL Bank:</strong> The brokerage upgraded the stock to 'add' from 'reduce' but cut its target price to Rs 350 per share from Rs 500 earlier. The stock was upgraded following the recent stock price correction, the brokerage added.
Kotak Institutional Equities on RBL Bank: The brokerage upgraded the stock to 'add' from 'reduce' but cut its target price to Rs 350 per share from Rs 500 earlier. The stock was upgraded following the recent stock price correction, the brokerage added.
<strong>Jefferies on Coal India:</strong> The stock has a 'buy' rating on the stock with a target at Rs 260 per share. Impact of government allowing commercial coal mining will be limited in 3-5 years, it said, adding that volume has disappointing on a year-to-date basis a concern, expect improvement post-monsoon.
Jefferies on Coal India: The stock has a 'buy' rating on the stock with a target at Rs 260 per share. Impact of government allowing commercial coal mining will be limited in 3-5 years, it said, adding that volume has disappointing on a year-to-date basis a concern, expect improvement post-monsoon.
<strong>Citi on Dr Lal Pathlabs:</strong> The brokerage maintainED a 'buy' call on the stock and raised its target to Rs 1,457 per share. The company is well placed to sustain healthy revenue growth and margin, it said, adding that industry dynamics to improve after a challenging phase over the last few years.
Citi on Dr Lal Pathlabs: The brokerage maintainED a 'buy' call on the stock and raised its target to Rs 1,457 per share. The company is well placed to sustain healthy revenue growth and margin, it said, adding that industry dynamics to improve after a challenging phase over the last few years.
<strong>Equirus on PI Industries:</strong> The brokerage initiated coverage of the stock with a long call and target at Rs 1,890 per share. Expect a 23 percent revenue CAGR over FY19-FY22, according to the brokerage. It also added that revenue growth would drive profit CAGR Of 27 percent.
Equirus on PI Industries: The brokerage initiated coverage of the stock with a long call and target at Rs 1,890 per share. Expect a 23 percent revenue CAGR over FY19-FY22, according to the brokerage. It also added that revenue growth would drive profit CAGR Of 27 percent.
<strong>CLSA on L&T:</strong> The brokerage reiterated a 'buy' call on the stock with a target at Rs 1,730 per share. Expect losses to decline on a turn in hydrocarbon and toll roads, the brokerage noted. It also said that the company has begun well on divesting assets.
CLSA on L&T: The brokerage reiterated a 'buy' call on the stock with a target at Rs 1,730 per share. Expect losses to decline on a turn in hydrocarbon and toll roads, the brokerage noted. It also said that the company has begun well on divesting assets.
<strong>Credit Suisse on Dabur:</strong> The brokerage has an 'outperform' call on the stock and raised its target to Rs 490 per share from Rs 475 earlier. The company is gaining market share in almost every product segment, the brokerage said, adding that strong volume growth delivered in June quarter and FY19 may come off.
Credit Suisse on Dabur: The brokerage has an 'outperform' call on the stock and raised its target to Rs 490 per share from Rs 475 earlier. The company is gaining market share in almost every product segment, the brokerage said, adding that strong volume growth delivered in June quarter and FY19 may come off.
Live TV

Ask Our Experts CNBC TV18